Projects
Immune modulation and tolerance induction
This TI Pharma research project is being conducted by a consortium consisting of The prevalence of inflammatory diseases like allergies and autoimmune diseases is increasing in the Western world. These diseases are often associated with a disturbed immune balance and a lack of immunological tolerance. Consequently, there is wide spread interest in the discovery and development of safe treatments that can modulate immune disorders and compensate for the lack of tolerance. Understanding the immune system and selecting appropriate immune modulators is crucial for generating safe and effective therapeutic and/or preventive treatment strategies, which is the main objective of the underlying project. In addition, the identified components might be particularly interesting as adjuvants for vaccines.
Partners: Danone Research, IQ Corporation, Pepscan Presto BVUniversity Medical Center Utrecht, Utrecht University, Vaxinostics, and VU University Medical Center Amsterdam
Full project title: Immune modulation and tolerance induction, prevention and inhibition of inflammatory diseases